These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 4898689)

  • 1. Glucose tolerance, free fatty acid, and serum insulin responses in patients with cirrhosis.
    Berkowitz D
    Am J Dig Dis; 1969 Oct; 14(10):691-9. PubMed ID: 4898689
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dynamic exploration of carbohydrate metabolism in liver cirrhosis. Determination of free fatty acids and insulin in the blood].
    Perreau P; Joubaud F; Cheguillaume J; Boyer J; Vernin H
    Sem Hop; 1972 Mar; 48(14):957-66. PubMed ID: 4339074
    [No Abstract]   [Full Text] [Related]  

  • 3. [Metabolic changes following glucose and tolbutamide loading in liver cirrhosis and their role in the pathogenesis of hepatogenic diabetes mellitus].
    Kopetz K; Wehrmann P
    Klin Wochenschr; 1970 Nov; 48(21):1265-76. PubMed ID: 5519414
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma insulin response to oral glucose load in hepatic cirrhosis.
    Jain AK; Agarwal BK; Bajpai HS; Gupta JP
    Indian J Med Res; 1983 Sep; 78():388-94. PubMed ID: 6370851
    [No Abstract]   [Full Text] [Related]  

  • 5. [Behavior of plasma/insulin, somatropin and NEFA after intravenous administration of tolbutamide in hepatic cirrhosis].
    Greco AV; Ghirlanda G; Rebuzzi A; Altomonte L; Manna R
    Minerva Med; 1976 Nov; 67(54):3525-32. PubMed ID: 995300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical investigation on abnormal glucose tolerance in liver cirrhosis.
    Kato K; Kikuchi S; Ito M
    Gastroenterol Jpn; 1976; 11(1):31-7. PubMed ID: 976684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pathogenesis of hepatogenic diabetes mellitus].
    Kopetz K
    Klin Wochenschr; 1970 Nov; 48(21):1259-65. PubMed ID: 4933224
    [No Abstract]   [Full Text] [Related]  

  • 8. [Measurement of plasma insulin and growth hormone after oral glucose tolerance test in patients with alcoholic cirrhosis].
    Descos L; M'Bendi S; Sassolas G; Audigier JC; Sidiqian N; Faure A; Bizollon CA
    Arch Fr Mal App Dig; 1974; 63(1):17-24. PubMed ID: 4441222
    [No Abstract]   [Full Text] [Related]  

  • 9. Insulin response in chronic alcoholism.
    Hed R; Nygren A; Sundblad L
    Lancet; 1968 Jan; 1(7534):145. PubMed ID: 4169630
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum glucose, insulin, and growth hormone in chronic hepatic cirrhosis.
    Samaan NA; Stone DB; Eckhardt RD
    Arch Intern Med; 1969 Aug; 124(2):149-52. PubMed ID: 5797073
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes of glycemia, insulinemia (IRI), and non-esterified free fatty acids during dynamic tests in a group of subjects with hepatic cirrhosis. The Rastinon test].
    Zandomeneghi R
    Minerva Med; 1970 Jan; 61(6):185-9. PubMed ID: 5412764
    [No Abstract]   [Full Text] [Related]  

  • 12. Carbohydrate metabolism in patients with primary hepatocellular carcinoma.
    Vinik AI; Pooler W
    Clin Sci Mol Med; 1973 Sep; 45(3):387-96. PubMed ID: 4361808
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pathogenesis of hepatogenic diabetes mellitus].
    Ratzmann KP
    Dtsch Z Verdau Stoffwechselkr; 1972; 32(5):361-70. PubMed ID: 4583562
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in plasma nonesterified fatty acids and glycerol during an induced hyperglycemia test by intravenous route in alcoholic and hemochromatotic cirrhosis].
    Poupon R; Simon M; Lenoir P; Bourel M
    Sem Hop; 1972 Jun; 48(29):2105-12. PubMed ID: 4343039
    [No Abstract]   [Full Text] [Related]  

  • 15. [Glucose tolerance, insulin secretion, levels of free fatty acids and growth hormone in hepatic cirrhosis].
    Marañón A; Durán S; Sanjose G; Romero E
    Rev Clin Esp; 1974 Feb; 132(4):299-306. PubMed ID: 4831267
    [No Abstract]   [Full Text] [Related]  

  • 16. [The response of serum glucose, free fatty acid and immunoreactive insulin to oral glucose and intravenous tolbutamide in normal, potentially diabetic and diabetic subjects].
    Bigelow-Sherman JD; Shima K; Borden EK; Foà PP; Penhallegon R
    Acta Diabetol Lat; 1970; 7(1):68-92. PubMed ID: 5493440
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma insulin; insulin resistance and glucose intolerance in children with bilharzial hepatic fibrosis.
    Zaki K; Kantoosh M; Hamam MA; Shoheib S; Mikhail N; Nour H; Zaki F
    Hepatogastroenterology; 1980 Dec; 27(6):417-22. PubMed ID: 7009363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma insulin and GH during oral glucose load in liver cirrhosis].
    Greco AV; Ghirlanda G; Altomonte L; Manna R; Rebuzzi AG
    Minerva Med; 1976 Jul; 67(35):2266-72. PubMed ID: 951048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of acute inhibition of lipolysis on operation of the glucose-fatty acid cycle in hepatic cirrhosis.
    Farrer M; Fulcher GR; Johnson AJ; Record CO; Alberti KG
    Metabolism; 1992 May; 41(5):465-70. PubMed ID: 1588824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetics of diabetes mellitus: glucose tolerance, serum insulin and free fatty acids in monozygotic twins].
    Daweke H; Grote W; Gries FA; Liebermeister H
    Dtsch Med Wochenschr; 1970 May; 95(18):983-8. PubMed ID: 5424947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.